TE_100
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | AluSx, SVA_B |
|---|---|
| TE superfamily | Alu, SVA |
| TE order | Retroposon, SINE |
| Gene | LZIC |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 43.39 |
| Counts of samples | TCGA_tumor:153; TCGA_normal:3; GTEx:0 |
| TSS | chr1(-):9956711 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_100.1 | LZIC | Chimeric | Non-coding | Non-coding | chr1(-):9930437,9930457,9931891,9931972,9932803,9932898,9934762,9934860,9935492,9935627,9936519,9936627,9942624,9942782,9943349,9948878,9956654,9956712 |
| teRNA_100.2 | LZIC | Chimeric | Non-coding | Non-coding | chr1(-):9930437,9930457,9931891,9931972,9932803,9932898,9934762,9934860,9935492,9935627,9936519,9936627,9942624,9942782,9943249,9948878,9956654,9956712 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
